{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:49:17Z","timestamp":1784371757518,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/000565"],"award-info":[{"award-number":["K\/ZDS\/000565"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02480-z","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:03:35Z","timestamp":1730808215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Good metabolic control is associated with decreased circulating factor VIIa\u2013 antithrombin complexes in type 2 diabetes: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Joanna","family":"Gasto\u0142","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Paszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Bryk-Wi\u0105zania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Matejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2480_CR1","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SRK, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet Lond Engl. 2010;375:2215\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(10)60484-9.","journal-title":"Lancet Lond Engl"},{"key":"2480_CR2","doi-asserted-by":"publisher","first-page":"e028923","DOI":"10.1161\/JAHA.122.028923","volume":"12","author":"V Jain","year":"2023","unstructured":"Jain V, Qamar A, Matsushita K, Vaduganathan M, Ashley KE, Khan MS, et al. Impact of diabetes on outcomes in patients hospitalized with acute myocardial infarction: insights from the atherosclerosis risk in communities study community surveillance. J Am Heart Assoc. 2023;12:e028923. https:\/\/doi.org\/10.1161\/JAHA.122.028923.","journal-title":"J Am Heart Assoc"},{"key":"2480_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.33963\/KP.a2022.0058","volume":"80","author":"P Jankowski","year":"2022","unstructured":"Jankowski P, Top\u00f3r-M\u0105dry R, G\u0105sior M, Ceg\u0142owska U, Gierlotka M, Kubica J, et al. Management and predictors of clinical events in 75 686 patients with acute myocardial infarction. Kardiologia Pol Pol Heart J. 2022;80:468\u201375. https:\/\/doi.org\/10.33963\/KP.a2022.0058.","journal-title":"Kardiologia Pol Pol Heart J"},{"key":"2480_CR4","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93\u2013621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123.","journal-title":"Circulation"},{"key":"2480_CR5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00125-023-05977-6","volume":"66","author":"AC Falkentoft","year":"2023","unstructured":"Falkentoft AC, Gerds TA, Zareini B, Knop FK, K\u00f8ber L, Torp-Pedersen C, et al. Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers. Diabetologia. 2023;66:2017\u201329. https:\/\/doi.org\/10.1007\/s00125-023-05977-6.","journal-title":"Diabetologia"},{"key":"2480_CR6","doi-asserted-by":"publisher","first-page":"e030131","DOI":"10.1161\/JAHA.123.030131","volume":"13","author":"JI Barzilay","year":"2024","unstructured":"Barzilay JI, Farag YMK, Durthaler J. Albuminuria: an underappreciated risk factor for cardiovascular disease. J Am Heart Assoc. 2024;13:e030131. https:\/\/doi.org\/10.1161\/JAHA.123.030131.","journal-title":"J Am Heart Assoc"},{"key":"2480_CR7","doi-asserted-by":"publisher","unstructured":"Shah HS, McGill JB, Hirsch IB, Wu C, Galecki A, de Boer IH, et al. Poor glycemic control is Associated with more Rapid kidney function decline after the Onset of Diabetic kidney disease. J Clin Endocrinol Metab. 2024;dgae044. https:\/\/doi.org\/10.1210\/clinem\/dgae044.","DOI":"10.1210\/clinem\/dgae044"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamacardio.2017.4228","volume":"3","author":"BM Scirica","year":"2018","unstructured":"Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, et al. Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at high cardiovascular risk: observations from the SAVOR-TIMI 53 Trial. JAMA Cardiol. 2018;3:155\u201363. https:\/\/doi.org\/10.1001\/jamacardio.2017.4228.","journal-title":"JAMA Cardiol"},{"key":"2480_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12933-021-01372-w","volume":"20","author":"AH Bryk-Wi\u0105zania","year":"2021","unstructured":"Bryk-Wi\u0105zania AH, Undas A. Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation. Cardiovasc Diabetol. 2021;20:191. https:\/\/doi.org\/10.1186\/s12933-021-01372-w.","journal-title":"Cardiovasc Diabetol"},{"key":"2480_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12933-022-01581-x","volume":"21","author":"AJ Camm","year":"2022","unstructured":"Camm AJ, Sabbour H, Schnell O, Summaria F, Verma A. Managing thrombotic risk in patients with diabetes. Cardiovasc Diabetol. 2022;21:160. https:\/\/doi.org\/10.1186\/s12933-022-01581-x.","journal-title":"Cardiovasc Diabetol"},{"key":"2480_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2020.06.003","volume":"307","author":"SP Grover","year":"2020","unstructured":"Grover SP, Mackman N. Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis. 2020;307:80\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.06.003.","journal-title":"Atherosclerosis"},{"key":"2480_CR12","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","volume":"29","author":"S Butenas","year":"2009","unstructured":"Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: which? Where? When? Arterioscler Thromb Vasc Biol. 2009;29:1989\u201396. https:\/\/doi.org\/10.1161\/ATVBAHA.108.177402.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0021-9150(97)00221-9","volume":"136","author":"K Ichikawa","year":"1998","unstructured":"Ichikawa K, Yoshinari M, Iwase M, Wakisaka M, Doi Y, Iino K, et al. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis. 1998;136:281\u20137. https:\/\/doi.org\/10.1016\/s0021-9150(97)00221-9.","journal-title":"Atherosclerosis"},{"key":"2480_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","volume":"113","author":"J Steffel","year":"2006","unstructured":"Steffel J, L\u00fcscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722\u201331. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.567297.","journal-title":"Circulation"},{"key":"2480_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover SP, Mackman N. Tissue factor. Arterioscler Thromb Vasc Biol. 2018;38:709\u201325. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309846.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR16","doi-asserted-by":"publisher","first-page":"291209","DOI":"10.1155\/2015\/291209","volume":"2015","author":"J Wang","year":"2015","unstructured":"Wang J, Ciaraldi TP, Samad F. Tissue factor expression in obese type 2 diabetic subjects and its regulation by antidiabetic agents. J Obes. 2015;2015:291209. https:\/\/doi.org\/10.1155\/2015\/291209.","journal-title":"J Obes"},{"key":"2480_CR17","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1161\/01.atv.17.11.2885","volume":"17","author":"F Khechai","year":"1997","unstructured":"Khechai F, Ollivier V, Bridey F, Amar M, Hakim J, de Prost D. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol. 1997;17:2885\u201390. https:\/\/doi.org\/10.1161\/01.atv.17.11.2885.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR18","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1210\/jc.2007-0933","volume":"92","author":"G Boden","year":"2007","unstructured":"Boden G, Vaidyula VR, Homko C, Cheung P, Rao AK. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose. J Clin Endocrinol Metab. 2007;92:4352\u20138. https:\/\/doi.org\/10.1210\/jc.2007-0933.","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.blre.2013.03.001","volume":"27","author":"K Winckers","year":"2013","unstructured":"Winckers K, ten Cate H, Hackeng TM. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev. 2013;27:119\u201332. https:\/\/doi.org\/10.1016\/j.blre.2013.03.001.","journal-title":"Blood Rev"},{"key":"2480_CR20","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/jth.15052","volume":"18","author":"AR Rezaie","year":"2020","unstructured":"Rezaie AR, Giri H. Anticoagulant and signaling functions of antithrombin. J Thromb Haemost JTH. 2020;18:3142\u201353. https:\/\/doi.org\/10.1111\/jth.15052.","journal-title":"J Thromb Haemost JTH"},{"key":"2480_CR21","doi-asserted-by":"publisher","unstructured":"Spiezia L, Campello E, Valle FD, Woodhams B, Simioni P. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation. Clin Chem Lab Med CCLM. 2017;55. https:\/\/doi.org\/10.1515\/cclm-2016-0399.","DOI":"10.1515\/cclm-2016-0399"},{"key":"2480_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jth.13274","volume":"14","author":"N Martinelli","year":"2016","unstructured":"Martinelli N, Girelli D, Baroni M, Guarini P, Sandri M, Lunghi B, et al. Activated factor VII\u2013antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study. J Thromb Haemost. 2016;14:655\u201366. https:\/\/doi.org\/10.1111\/jth.13274.","journal-title":"J Thromb Haemost"},{"key":"2480_CR23","doi-asserted-by":"publisher","unstructured":"Paszek E, Pociask E, Z\u0105bczyk M, Butenas S, Undas A. Activated factor XI is associated with increased factor VIIa - antithrombin complexes in stable coronary artery disease: impact on cardiovascular outcomes. Eur J Clin Invest. 2022;e13857. https:\/\/doi.org\/10.1111\/eci.13857.","DOI":"10.1111\/eci.13857"},{"key":"2480_CR24","volume-title":"Diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","author":"Definition","year":"2006","unstructured":"Definition. and Diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation. Geneva, Switzerland: World Health Organization; 2006."},{"key":"2480_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12933-019-0850-0","volume":"18","author":"AH Bryk","year":"2019","unstructured":"Bryk AH, Prior SM, Plens K, Konieczynska M, Hohendorff J, Malecki MT, et al. Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis. Cardiovasc Diabetol. 2019;18:49. https:\/\/doi.org\/10.1186\/s12933-019-0850-0.","journal-title":"Cardiovasc Diabetol"},{"key":"2480_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763\u2013816. https:\/\/doi.org\/10.1093\/eurheartj\/ehx095.","journal-title":"Eur Heart J"},{"key":"2480_CR27","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"2480_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.33963\/KP.a2023.0031","volume":"81","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. Wytyczne ESC 2023 dotycz\u0105ce leczenia chor\u00f3b sercowo-naczyniowych u pacjent\u00f3w z cukrzyc\u0105. Pol Heart J Kardiologia Pol. 2023;81:103\u2013200.","journal-title":"Pol Heart J Kardiologia Pol"},{"key":"2480_CR29","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/j.1538-7836.2007.02710.x","volume":"5","author":"KG Mann","year":"2007","unstructured":"Mann KG, Whelihan MF, Butenas S, Orfeo T. Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost. 2007;5:2055\u201361. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02710.x.","journal-title":"J Thromb Haemost"},{"key":"2480_CR30","doi-asserted-by":"publisher","unstructured":"Lundblad RL, Kingdon HS, Mann KG. [14] Thrombin. Methods Enzymol., vol. 45, Elsevier; 1976, pp. 156\u201376. https:\/\/doi.org\/10.1016\/S0076-6879(76)45017-6","DOI":"10.1016\/S0076-6879(76)45017-6"},{"key":"2480_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1160\/TH13-07-0566","volume":"111","author":"M Konieczynska","year":"2014","unstructured":"Konieczynska M, Fil K, Bazanek M, Undas A. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Thromb Haemost. 2014;111:685\u201393. https:\/\/doi.org\/10.1160\/TH13-07-0566.","journal-title":"Thromb Haemost"},{"key":"2480_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1182\/blood-2017-07-798306","volume":"131","author":"J Cieslik","year":"2018","unstructured":"Cieslik J, Mrozinska S, Broniatowska E, Undas A. Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study. Blood. 2018;131:797\u2013807. https:\/\/doi.org\/10.1182\/blood-2017-07-798306.","journal-title":"Blood"},{"key":"2480_CR33","doi-asserted-by":"publisher","first-page":"16407","DOI":"10.20452\/pamw.16407","volume":"133","author":"NA Zieleniewska","year":"2023","unstructured":"Zieleniewska NA, Szum-Jakubowska A, Chlabicz M, Jamio\u0142kowski J, Kowalska I, Kami\u0144ski KA. The prevalence of diabetes and prediabetes: a population-based study. Pol Arch Intern Med. 2023;133:16407. https:\/\/doi.org\/10.20452\/pamw.16407.","journal-title":"Pol Arch Intern Med"},{"key":"2480_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2213-8587(18)30303-6","volume":"7","author":"S Basu","year":"2019","unstructured":"Basu S, Yudkin JS, Kehlenbrink S, Davies JI, Wild SH, Lipska KJ, et al. Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis. Lancet Diabetes Endocrinol. 2019;7:25\u201333. https:\/\/doi.org\/10.1016\/S2213-8587(18)30303-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2480_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12902-022-01026-2","volume":"22","author":"SV Arnold","year":"2022","unstructured":"Arnold SV, Tang F, Cooper A, Chen H, Gomes MB, Rathmann W, et al. Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER. BMC Endocr Disord. 2022;22:111. https:\/\/doi.org\/10.1186\/s12902-022-01026-2.","journal-title":"BMC Endocr Disord"},{"key":"2480_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jth.13899","volume":"16","author":"NC Olson","year":"2018","unstructured":"Olson NC, Raffield LM, Lange LA, Lange EM, Longstreth WT, Chauhan G, et al. Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk. J Thromb Haemost JTH. 2018;16:19\u201330. https:\/\/doi.org\/10.1111\/jth.13899.","journal-title":"J Thromb Haemost JTH"},{"key":"2480_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5001\/omj.2010.52","volume":"25","author":"RS El-Hagracy","year":"2010","unstructured":"El-Hagracy RS, Kamal GM, Sabry IM, Saad AA, Abou El Ezz NF, Nasr HAR. Tissue factor, tissue factor pathway inhibitor and factor vii activity in cardiovascular complicated type 2 diabetes mellitus. Oman Med J. 2010;25:173\u20138. https:\/\/doi.org\/10.5001\/omj.2010.52.","journal-title":"Oman Med J"},{"key":"2480_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.mbc.0000304148.26525.da","volume":"19","author":"EA El-Ghoroury","year":"2008","unstructured":"El-Ghoroury EA, El-Din HG, Abdel-Kader M, Ragab S. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis Int J Haemost Thromb. 2008;19:7\u201313. https:\/\/doi.org\/10.1097\/01.mbc.0000304148.26525.da.","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"2480_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archinte.161.1.98","volume":"161","author":"JA D\u2019Elia","year":"2001","unstructured":"D\u2019Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Keough J, Pendse S, et al. Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications. Arch Intern Med. 2001;161:98. https:\/\/doi.org\/10.1001\/archinte.161.1.98.","journal-title":"Arch Intern Med"},{"key":"2480_CR40","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.atv.15.8.1114","volume":"15","author":"K Kario","year":"1995","unstructured":"Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol. 1995;15:1114\u201320. https:\/\/doi.org\/10.1161\/01.atv.15.8.1114.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR41","doi-asserted-by":"publisher","first-page":"e2348333","DOI":"10.1001\/jamanetworkopen.2023.48333","volume":"6","author":"N Mahemuti","year":"2023","unstructured":"Mahemuti N, Zou J, Liu C, Xiao Z, Liang F, Yang X. Urinary albumin-to-creatinine ratio in normal range, cardiovascular health, and all-cause mortality. JAMA Netw Open. 2023;6:e2348333. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.48333.","journal-title":"JAMA Netw Open"},{"key":"2480_CR42","doi-asserted-by":"publisher","first-page":"16208","DOI":"10.20452\/pamw.16208","volume":"132","author":"A Undas","year":"2022","unstructured":"Undas A. Statins in prevention of thromboembolic events: from seminal studies to recent advances. Pol Arch Intern Med. 2022;132:16208. https:\/\/doi.org\/10.20452\/pamw.16208.","journal-title":"Pol Arch Intern Med"},{"key":"2480_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.thromres.2024.03.007","volume":"236","author":"J Kristiansen","year":"2024","unstructured":"Kristiansen J, Grove EL, Sj\u00far\u00f0arson T, Mohr M, Kristensen SD, Hvas A-M. Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease. Thromb Res. 2024;236:220\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2024.03.007.","journal-title":"Thromb Res"},{"key":"2480_CR44","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1111\/jth.15043","volume":"18","author":"A Blasi","year":"2020","unstructured":"Blasi A, von Meijenfeldt FA, Adelmeijer J, Calvo A, Iba\u00f1ez C, Perdomo J, et al. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J Thromb Haemost. 2020;18:2646\u201353. https:\/\/doi.org\/10.1111\/jth.15043.","journal-title":"J Thromb Haemost"},{"key":"2480_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1160\/TH14-02-0156","volume":"113","author":"E Campello","year":"2015","unstructured":"Campello E, Zabeo E, Radu CM, Spiezia L, Gavasso S, Fadin M, et al. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events. Thromb Haemost. 2015;113:85\u201396. https:\/\/doi.org\/10.1160\/TH14-02-0156.","journal-title":"Thromb Haemost"},{"key":"2480_CR46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.thromres.2020.08.044","volume":"196","author":"LE Landgrebe","year":"2020","unstructured":"Landgrebe LE, Juhl CB, Andersen V, Moitinho-Silva L, Bang C, Bladbjerg EM. Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1\u2009+\u20092 in patients with morbid obesity. Thromb Res. 2020;196:260\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2020.08.044.","journal-title":"Thromb Res"},{"key":"2480_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2021.11.002","volume":"97","author":"LE Landgrebe","year":"2022","unstructured":"Landgrebe LE, Andersen V, Bang C, Moitinho-Silva L, Schwarz H, Juhl CB, et al. High-fat meals do not affect thrombin formation and fibrin clot lysis in individuals with obesity during intentional weight loss. Nutr Res N Y N. 2022;97:1\u201310. https:\/\/doi.org\/10.1016\/j.nutres.2021.11.002.","journal-title":"Nutr Res N Y N"},{"key":"2480_CR48","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/01.atv.16.11.1327","volume":"16","author":"R Kapur","year":"1996","unstructured":"Kapur R, Hoffman CJ, Bhushan V, Haltin MB. Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol. 1996;16:1327\u201332. https:\/\/doi.org\/10.1161\/01.atv.16.11.1327.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR49","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.atv.20.11.2494","volume":"20","author":"EM Bladbjerg","year":"2000","unstructured":"Bladbjerg EM, M\u00fcnster AM, Marckmann P, Keller N, Jespersen J. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1\u2009+\u20092 in patients with stable angina pectoris and coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2494\u20139. https:\/\/doi.org\/10.1161\/01.atv.20.11.2494.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2480_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.blre.2014.12.005","volume":"29","author":"M Pieters","year":"2015","unstructured":"Pieters M, de Maat MPM. Diet and haemostasis - a comprehensive overview. Blood Rev. 2015;29:231\u201341. https:\/\/doi.org\/10.1016\/j.blre.2014.12.005.","journal-title":"Blood Rev"},{"key":"2480_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-02097-8","volume":"23","author":"I Valencia","year":"2024","unstructured":"Valencia I, Lumpuy-Castillo J, Magalhaes G, S\u00e1nchez-Ferrer CF, Lorenzo \u00d3, Peir\u00f3 C. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75. https:\/\/doi.org\/10.1186\/s12933-023-02097-8.","journal-title":"Cardiovasc Diabetol"},{"key":"2480_CR52","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1160\/TH09-08-0606","volume":"103","author":"L Spiezia","year":"2010","unstructured":"Spiezia L, Rossetto V, Campello E, Gavasso S, Woodhams B, Tormene D, et al. Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. Thromb Haemost. 2010;103:1188\u201392. https:\/\/doi.org\/10.1160\/TH09-08-0606.","journal-title":"Thromb Haemost"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02480-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:07:08Z","timestamp":1730808428000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02480-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02480-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the local ethics committee. Study participants provided informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}